Location: Home
  • search
  • go
  • Relate News
  • 1/8/2026China Convenes National Health Work Conference to Outline 2026 Priorit...
  • 1/8/2026NMPA Moves to Accelerate Approval of Overseas-Approved Drugs for Urgen...
  • 1/8/2026NMPA Clarifies Application of ICH Q12 to Strengthen Pharmaceutical Lif...
  • 1/8/2026China to Implement ICH E6(R3) Guideline for Drug Clinical Trial Qualit...
  • 1/8/2026Curium's IND for 177Lu-PSMA-I&T Accepted for Review in China
  • 1/8/2026China's Pet Obesity Sparks Biotech Race for Weight-Loss Drugs
  • 1/8/2026Sinovac Secures Exclusive 2026 Influenza Vaccine Supply Contract with ...
  • 1/8/2026AskBio Receives FDA Acceptance of IND for AB-1009 Gene Therapy
  • 1/8/2026HUTCHMED Reports Positive Phase III Results for Sovleplenib in China
  • 1/8/2026BioRay Files for Hong Kong IPO to Advance Innovative Biologics Portfol...
  • 1/8/2026Hengrui Wins China Approval for Retlirafusp Alfa
  • 1/8/2026China Revises Drug Administration Law Implementation Rules to Boost In...
  • 1/8/2026China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...
  • 1/8/2026Luye's Ruoxinlin NDA Accepted in China for Anxiety Disorder Treatment
  • 1/8/2026Hansoh Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
  • 1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC
  • 1/8/2026Chinese Drug Makers Hit Record US$136B in Global Out-Licensing Deals i...
  • 1/8/2026Asia Emerges as the New Epicenter of Global Biopharma Innovation: McKi...
  • 1/7/2026Epigenic Advances FIC Epigenetic HBV Therapy With U.S. IND Clearance
  • 1/7/2026Structure Thera Secures $100M Upfront in Roche and Genentech Patent Li...
  • 1/7/2026GenHouse Pharma Advances MAT2A Inhibitor GH31 With China Trial Approva...
  • 1/7/2026GenEditBio Secures FDA IND Clearance for FIC In Vivo Genome Editing Ey...
  • 1/7/2026Shanghai ArkBio Secures China Approval for Aizhida in ADHD
  • 1/7/2026NMPA Issues Announcement on Strengthening Oversight of Contract Drug M...
  • 1/7/2026China's National Health Literacy Level Reaches 33.69% in 2025
  • 1/7/2026Anlong Secures ~CNY 100M in Series B+ Financing and Signs Major Intern...
  • 1/7/2026Wiseheart Medval Raises Over CNY 100M in Series A Financing
  • 1/7/2026ImmuneOnco and Axion Terminate Clinical Development of IMM2510/AXN-251...
  • 1/7/2026ReviR Secures China CTN Clearance for FIC CMT Drug Candidate RTX-117
  • 1/7/2026Sanofi's Redemplo Wins China Approval for Rare Lipid Disorder FCS
  • Page:10/819 Total number of articles:24553: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group